Search Results - Massimo Carella

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Empagliflozin Repurposing for Lafora Disease: A Pilot Clinical Trial and Preclinical Investigation of Novel Therapeutic Targets

    Empagliflozin Repurposing for Lafora Disease: A Pilot Clinical Trial and Preclinical Investigation of Novel Therapeutic Targets by Giuseppe d’Orsi, Antonella Liantonio, Paola Imbrici, Nicola Gambacorta, Giorgia Dinoi, Cosimo Damiano Altomare, DEFEAT-LD Study Group, Massimo Carella

    Published 2025-05-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Adverse effects of antiseizure medications: a review of the impact of pharmacogenetics and drugs interactions in clinical practice

    Adverse effects of antiseizure medications: a review of the impact of pharmacogenetics and drugs interactions in clinical practice by Michela De Bellis, Giuseppe d’Orsi, Egidio Maria Rubino, Claudia Arigliano, Massimo Carella, Vittorio Sciruicchio, Antonella Liantonio, Annamaria De Luca, Paola Imbrici

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Generation of a human induced pluripotent stem cell line (CIBIOi007-A) from a Lafora disease patient

    Generation of a human induced pluripotent stem cell line (CIBIOi007-A) from a Lafora disease patient by Gabriele Trentini, Giulia Cazzanelli, Marina Cardano, Orazio Palumbo, Mario Benvenuto, Pietro Palumbo, Francesca Agriesti, Claudia Piccoli, Luciano Conti, DEFEAT-LD Study Group, Massimo Carella, Graziano Lolli, Giuseppe d’Orsi

    Published 2025-09-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: